Exact Sciences
EXAS
#1382
Rank
C$17.75 B
Marketcap
$96.07
Share price
2.34%
Change (1 day)
-5.23%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : C$9.05 B

According to Exact Sciences's latest financial reports the company's total assets are C$9.05 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$8.58 B1.58%
2022-12-31C$8.44 B-0.13%
2021-12-31C$8.46 B34.7%
2020-12-31C$6.28 B38.2%
2019-12-31C$4.54 B118.6%
2018-12-31C$2.07 B176.27%
2017-12-31C$0.75 B48.52%
2016-12-31C$0.50 B0.23%
2015-12-31C$0.50 B39.33%
2014-12-31C$0.36 B132.59%
2013-12-31C$0.15 B39.6%
2012-12-31C$0.11 B13.31%
2011-12-31C$98.62 M2.08%
2010-12-31C$96.6 M255.85%
2009-12-31C$27.14 M276.72%
2008-12-31C$7.2 M-49.64%
2007-12-31C$14.3 M-48.51%
2006-12-31C$27.78 M-36.93%
2005-12-31C$44.06 M-28.04%
2004-12-31C$61.22 M34.68%
2003-12-31C$45.46 M-42.53%
2002-12-31C$79.1 M-21.3%
2001-12-31C$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$1.47 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.67 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.98 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
C$188.66 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France